Product defect correction - potential for blank labelling to pose risk of accidental misuse
Therapeutic Goods Administration (TGA)
Australian Government Department of Health
Main menu
- Home
- Safety information
- Consumers
- Health professionals
- Industry
- SME Assist
- When to engage with the TGA
- Basics of therapeutic goods regulation
- Meeting your obligations workshops
- Presentations and webinars
- Overview of applying for market authorisation
- Overview of medical devices and IVD regulation
- Researcher considerations
- Interactive decision tools
- Useful resources for business and researchers
- Regulation basics
- How therapeutic goods are regulated in Australia
- Australian Register of Therapeutic Goods
- Industry educational materials
- Legislation & legislative instruments
- Advertising hub
- Labelling & packaging
- Ingredients in therapeutic goods
- Exporting therapeutic goods
- Importing therapeutic goods
- Clinical trials
- Cosmetics
- EU and ICH guidelines
- Safety information for industry
- Prescription medicines
- Over-the-counter medicines
- Complementary medicines
- Sunscreens
- Medical devices & IVDs
- Biologicals
- Blood and blood components
- Other therapeutic goods
- Manufacturing therapeutic goods
- Scheduling of medicines & poisons
- SME Assist
- About the TGA
- News room
